A Grim link: the association between subclinical atherosclerosis and epigenetic age.

Eur Heart J

Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.

Published: August 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393075PMC
http://dx.doi.org/10.1093/eurheartj/ehad326DOI Listing

Publication Analysis

Top Keywords

grim link
4
link association
4
association subclinical
4
subclinical atherosclerosis
4
atherosclerosis epigenetic
4
epigenetic age
4
grim
1
association
1
subclinical
1
atherosclerosis
1

Similar Publications

Background: The tumor microenvironment (TME) performs a crucial function in the tumorigenesis and response to immunotherapies of clear cell renal cell carcinoma (ccRCC). However, a lack of recognized pre-clinical TME-based risk models poses a great challenge to investigating the risk factors correlated with prognosis and treatment responses for patients with ccRCC.

Methods: Stromal and immune contexture were assessed to calculate the TMErisk score of a large sample of patients with ccRCC from public and real-world cohorts using machine-learning algorithms.

View Article and Find Full Text PDF

A case-control study: epigenetic age acceleration in psoriasis.

Arch Dermatol Res

June 2024

Department of Dermatology, Warren Alpert Medical School, Brown University, 339 Eddy Street, Providence, RI, 02903, USA.

Article Synopsis
  • Psoriasis (PsO) is a long-lasting skin condition that can also cause joint problems called psoriatic arthritis (PsA) and is linked to other health issues.
  • A study compared 20 people with PsO to 20 people without it, looking at their DNA to check for signs of aging.
  • The study found no big differences in aging for most PsO cases, but those with PsA showed signs of faster aging due to inflammation, suggesting more research is needed on how PsO affects aging.
View Article and Find Full Text PDF

Comprehensive analysis of ALG3 in pan-cancer and validation of ALG3 as an onco-immunological biomarker in breast cancer.

Aging (Albany NY)

February 2024

Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.

ALG3 has significant modulatory function in the process of tumor development. Yet how ALG3 involves in the advancement of different malignancies isn't fully understood. We performed a pan-cancer assessment on ALG3 utilizing datasets from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) to examine its tumor-related roles across malignancies and its link to particular molecules and cells in the tumor microenvironment (TME).

View Article and Find Full Text PDF

TRPV6 Channel Is Involved in Pancreatic Ductal Adenocarcinoma Aggressiveness and Resistance to Chemotherapeutics.

Cancers (Basel)

December 2023

Laboratory of Cell Physiology, INSERM U1003, Laboratory of Excellence Ion Channel Science and Therapeutics, Department of Biology, Faculty of Science and Technologies, University of Lille, 59650 Villeneuve d'Ascq, France.

Pancreatic ductal adenocarcinoma (PDAC) stands as a highly aggressive and lethal cancer, characterized by a grim prognosis and scarce treatment alternatives. Within this context, TRPV6, a calcium-permeable channel, emerges as a noteworthy candidate due to its overexpression in various cancers, capable of influencing the cell behavior in different cancer entities. Nonetheless, the exact expression pattern and functional significance of TRPV6 in the context of PDAC remains enigmatic.

View Article and Find Full Text PDF

A Grim link: the association between subclinical atherosclerosis and epigenetic age.

Eur Heart J

August 2023

Department of Stem Cell and Regenerative Biology and the Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!